Dr. Remuzzi is the Head of Nephrology and Dialysis and Chairman of the Department of Transplantation at Bergamo Hospital and head of the Negri Bergamo Laboratories, which is devoted to the study of renal disease and a center that he has directed since 1984. As a recognized leader in the field of kidney regeneration, Dr. Remuzzi recently authored a review article in the prestigious medical journal, The Lancet, on the field of kidney regeneration. As director of the Negri Bergamo Laboratories and the affiliated Clinical Research Center for Rare Diseases, both divisions of the Mario Negri Institute for Pharmacological Research, Dr. Remuzzi leads a diverse team of researchers studying human renal diseases and their corresponding experimental models from the perspective of pathophysiology and therapeutic intervention. Dr. Remuzzi's work and research has helped drive major advances in many areas of nephrology, including transplant immunology and tolerance. Dr. Remuzzi completed his medical training at the University of Pavia and received specialty training in Hematology and Nephrology at the University of Milan. He has been awarded honorary memberships of the Association of American Physicians and the British Royal College of Physicians and has authored and co-authored more than 1,000 scientific articles, reviews and monographs.
Ben Humphreys, M.D., Ph.D.
Dr. Humphreys is an Assistant Professor of Medicine at Harvard Medical School and Principal Faculty Member of the Harvard Stem Cell Institute and Co-Director of the Harvard Stem Cell Institute Kidney Program. He received a bachelor's degree from Harvard College and M.D. and Ph.D. degrees from Case Western Reserve University. Dr. Humphreys completed a residency in Internal Medicine at Massachusetts General Hospital and a fellowship in Nephrology at Brigham and Women's Hospital in Boston. He is the recipient of a Harvard Stem Cell Institute Seed Grant, the
|SOURCE Tengion, Inc.|
Copyright©2010 PR Newswire.
All rights reserved